Cargando…
Ribonucleotide Reductase Large Subunit M1 Predicts Poor Survival Due to Modulation of Proliferative and Invasive Ability of Gastric Cancer
OBJECTIVES: We aimed to investigate the prognostic value of RRM1 in GC patients. METHODS: A total of assessable 389 GC patients with clinicopathological and survival information were enrolled from City of Hope (COH, n = 67) and Zhejiang University (ZJU, n = 322). RRM1 protein expression was determin...
Autores principales: | Wang, Qinchuan, Liu, Xiyong, Zhou, Jichun, Huang, Yasheng, Zhang, Shengjie, Shen, Jianguo, Loera, Sofia, Yuan, Xiaoming, Chen, Wenjun, Jin, Mei, Shibata, Stephen, Liu, Yingbin, Chu, Peiguo, Wang, Linbo, Yen, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726373/ https://www.ncbi.nlm.nih.gov/pubmed/23922955 http://dx.doi.org/10.1371/journal.pone.0070191 |
Ejemplares similares
-
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
por: Zhang, Hang, et al.
Publicado: (2014) -
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers
por: Liu, Xiyong, et al.
Publicado: (2013) -
Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients
por: Cho, Er-Chieh, et al.
Publicado: (2014) -
Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy
por: Wijerathna, Sanath R., et al.
Publicado: (2011) -
Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer
por: Yin, Xin, et al.
Publicado: (2023)